New research has shown that ultrasmall Cornell Prime Dots, or C’Dots, which are among the nanocarriers for therapeutics once thought to be viable only by injection, have the potential to be administered orally.
Read the story in the Cornell Chronicle.
Ask an ambassador: How my first-year writing seminar enriched my four years
A&S Student Ambassador
